The safety of octinoxate has been a topic of debate. Regulatory bodies like the FDA and the European Medicines Agency have approved its use in sunscreens at concentrations up to a certain limit. However, some studies have raised concerns about its potential endocrine-disrupting effects, which could theoretically affect cancer risk.
